|
FDA approves Spevigo for pustular psoriasis
|
Fri-14-10-2022, 15:11 PM
Update: The European Medicine Agency’s Committee for Medicinal Products for Human Use (CHMP) recommended the granting of a conditional market authorization for Boehringer Ingelheim’s spesolimab as first in class treatment option for generalized pustular psoriasis (GPP) flares in adults.
|
|
« Next Oldest | Next Newest »
|
| Messages In This Thread |
|
FDA approves Spevigo for pustular psoriasis - by Fred - Sat-03-09-2022, 11:05 AM
RE: FDA approves Spevigo for pustular psoriasis - by Caroline - Sun-04-09-2022, 07:51 AM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Fri-14-10-2022, 15:11 PM
RE: FDA approves Spevigo for pustular psoriasis - by Caroline - Fri-14-10-2022, 16:30 PM
RE: FDA approves Spevigo for pustular psoriasis - by Forest Walker - Sat-15-10-2022, 13:25 PM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Sat-15-10-2022, 20:15 PM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Wed-14-12-2022, 14:29 PM
RE: FDA approves Spevigo for pustular psoriasis - by Fred - Wed-20-03-2024, 17:06 PM
|
| Possibly Related Threads… | |||||
| Thread | Author | Replies | Views | Last Post | |
|
Pustular psoriasis triggered by Mpox vaccine | Fred | 0 | 600 |
Sun-18-08-2024, 12:27 PM Last Post: Fred |
|
|
Pustular psoriasis study in France | Fred | 1 | 1,382 |
Mon-26-02-2024, 21:11 PM Last Post: Caroline |
|
|
Pustular psoriasis in Europe | Fred | 1 | 1,787 |
Wed-31-01-2024, 17:52 PM Last Post: Caroline |
|
|
NICE Approves Sotyktu for psoriasis in England | Fred | 0 | 1,428 |
Wed-28-06-2023, 16:42 PM Last Post: Fred |
|
|
FDA Approves Sotyktu for psoriasis | Fred | 9 | 5,965 |
Fri-24-03-2023, 21:44 PM Last Post: Kat |
Health Boards
